Drug-resistant Mycobacterium tuberculosis among new tuberculosis patients, Yangon, Myanmar.
Phyu
Sabai
S
Ti
Ti
T
Jureen
Roland
R
Hmun
Thandar
T
Myint
Hlaing
H
Htun
Aye
A
Grewal
Harleen M S
HM
Bjorvatn
Bjarne
B
D017088:AIDS-Related Opportunistic Infections / Q000150:complications; D024881:Drug Resistance, Bacterial; D004977:Ethambutol / Q000494:pharmacology; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology; D002052:Myanmar / Q000453:epidemiology; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D011718:Pyrazinamide / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D017211:Treatment Failure; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology
D011718:Pyrazinamide; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin